Cargando…
Use of integrated clinical trial protocols – A survey in early medicines development
Purpose: To collect information on the use of integrated protocols in early clinical medicines development. Materials and methods: The questionnaire was mailed in fall 2014 to members of human pharmacology societies in Europe for anonymous responses via the online tool SurveyMonkey(®). Results: 97 r...
Autores principales: | Erb-Zohar, Katharina, Sourgens, Hildegard, Breithaupt-Groegler, Kerstin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914155/ https://www.ncbi.nlm.nih.gov/pubmed/29451470 http://dx.doi.org/10.5414/CP203206 |
Ejemplares similares
-
Unintended drug exposure during pregnancy in clinical trials – a survey in early drug development
por: Erb-Zohar, Katharina, et al.
Publicado: (2021) -
How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum
por: Rengelshausen, Jens, et al.
Publicado: (2021) -
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
por: Breithaupt-Groegler, Kerstin, et al.
Publicado: (2017) -
European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development—Be Prepared
por: Hardman, Tim, et al.
Publicado: (2019) -
EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
por: Van Bortel, Luc, et al.
Publicado: (2018)